Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 2 days agoIn the process, Lilly’s valuation soared past $750 billion, making it the world’s largest drugmaker...
Second Chinese drugmaker seeks approval for Ozempic generic
Reuters· 1 day ago, opens new tab said this week its subsidiary was seeking approval to sell the drug to control blood...
Second Chinese drugmaker seeks approval for Ozempic generic
AOL· 2 days agoA second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's blockbuster diabetes drug Ozempic in China. Livzon Pharmaceutical Group said ...
CD&R Leads Bidding for Drugmaker Stada as Owners Seek €11 Billion
Bloomberg· 4 days agoHave a confidential tip for our reporters? Clayton Dubilier & Rice is emerging as frontrunner to...
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 3 days agoSTOCK ALERT Danish drugmaker Novo Nordisk shares were under pressure on Tuesday after Sen. Bernie...
Tempus AI shares jump 8% in strong Nasdaq debut as US IPO market thaws
Reuters via Yahoo Finance· 1 day agoThe company boasts of several big investors including Alphabet's Google, investment managers...
CD&R Leads Bidding for Drugmaker Stada as Owners Seek €11 Billion
Bloomberg via Yahoo Finance· 4 days ago(Bloomberg) -- Clayton Dubilier & Rice is emerging as frontrunner to acquire Stada Arzneimittel AG...
Making the case for Wegovy coverage: Drug keeps weight off for 4 years, aids heart health
BenefitsPRO· 4 days agoDrugmaker Novo Nordisk has released two new trial results that could strengthen the case for...
Novel Drug for Rare Chronic Liver Disease Wins Conditional FDA Approval
MedPage Today· 5 days agoThe FDA granted accelerated approval to oral elafibranor (Iqirvo) for treating primary biliary...
Amid big Bayer shakeup, drugmaker loses Berkeley-based biotech chief - San Francisco Business Times
The Business Journals· 4 days agoJens Vogel, who as global head of biotech led Bayer AG's push into cell therapy manufacturing from...